Thus far, BIEL has done what they need to do, on a shoe string, to get to this point. While I believe they won't do anything to purposely screw the shareholders, they will definitely do what they believe is in the best interest of growth of the company. That means uplisting at some point. Depending on the route taken, BIEL needs to close with a share value between 2.00 - 4.00/share to uplist on Nasdaq. While it's possible that they get to .20 and do a 10/1, I, and this is strictly opinion, believe it's much more likely they do a 100/1 in the .03 - .05 range. I've been wrong before. It won't hurt my feelings. Either way, it would only make the smaller share count look feeble to smaller share holders. You wouldn't lose any money and the company would become available to fund investors. While an R/S is, usually, thought of as a bad thing, it's just what the Dr. ordered in this case. With 18-20ish billion shares outstanding, there is 0% chance of uplist without an R/S. It's when not if it happens. The only people that should be worried about an R/S are shorts and day traders. Those that have been watching and waiting in the 10 year range are not rattled by the idea. They know that the water is about to overflow the bucket.